𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Lipoprotein Modulation of Subendothelial Heparan Sulfate Proteoglycans (Perlecan) and Atherogenicity

✍ Scribed by Sivaram Pillarisetti


Book ID
114341914
Publisher
Elsevier Science
Year
2000
Tongue
English
Weight
200 KB
Volume
10
Category
Article
ISSN
1050-1738

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Heparan sulfate proteoglycans in experim
✍ Karin Conde-Knape 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 126 KB 👁 1 views

## Abstract Proteoglycans are ubiquitous extracellular proteins that serve a variety of functions throughout the organism. Unlike other glycoproteins, proteoglycans are classified based on the structure of the glycosaminoglycan carbohydrate chains, not the core proteins. Perlecan, a member of the h

An association study of a polymorphism i
✍ Rosenmann, Hanna ;Meiner, Zeev ;Kahana, Esther ;Aladjem, Zoja ;Friedman, Gideon 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 62 KB 👁 3 views

## Abstract Accumulating evidence indicates that the heparan‐sulfate‐proteoglycan (perlecan, HSPG2), as well as other specific proteoglycans, are involved in amyloidogenesis and tau aggregation in Alzheimer's disease (AD). Moreover, the HSPG2 is located on chromosome 1p36, a region of linkage to la

Internalization but not binding of throm
✍ Shuxia Wang; Mary E. Herndon; Sripriya Ranganathan; Svetlana Godyna; Jack Lawler 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 197 KB

## Abstract The amino‐terminal domain of the extracellular matrix (ECM) protein thrombospondin‐1 (TSP‐1) mediates binding to cell surface heparan sulfate proteoglycans (HSPG) as well as binding to the endocytic receptor, low density lipoprotein‐related protein (LRP‐1). We previously found that reco